In 2020, US regulators pulled Zantac off shelves due to fears that a key ingredient, ranitidine, could turn into a substance that may cause cancer when exposed to heat. That move led to tens of ...

Trelegy is a one-dose daily, triple therapy inhaler that combines three active ingredients ... Notably, GSK’s previously sold antacid Zantac may have caused cancer in some patients.

Despite Zantac’s initial success with annual sales topping $1bn following its US release in 1983, US regulators pulled the drug off shelves in 2020 due to fears that a key ingredient, ranitidine, ...

To reduce exposure, it is important to limit the consumption of processed meats, use less nitrate-preserved foods and choose fresh and minimally processed ingredients. There have several cases ...

GSK had pulled blockbuster heartburn drug Zantac from sale in the US in 2019, following claims that it contained ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

GSK said total sales fell by two per cent in the third quarter Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and ...

GSK (GSK) used its third-quarter trading update to draw a definitive line under the damaging litigation around its now discontinued heartburn medicine Zantac, by agreeing a settlement earlier in ...

The FDA proposed a ban on phenylephrine, a common decongestant found in cold and cough medications. Here’s why and a list of ...

"We also resolved the vast majority of Zantac litigation in the quarter, to remove uncertainty, and so we can focus forward. All this means we are on track to deliver our 2024 guidance, and we are ...